RUNX1 and cancer: The percentages of RUNX1+ cells, CD8+RUNX1+T/CD8+T cells, and CD103+CD8+RUNX1+T/CD8+T cells were all higher in cancer tissues than in paracancer tissues (Figures 4A–C).